Sep 04, 2019
Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference
Aug 05, 2019
Prometic Life Sciences to Present at Canaccord 39th Annual Growth Conference
Jun 14, 2019
Prometic Presents New Data on PBI-4050 and its Mechanism of Action on Kidney Fibrosis at the 56th ERA/EDTA Congress
May 30, 2019
Prometic Life Sciences to Present at Two Upcoming June Investor Conferences
May 22, 2019
Prometic presents new PBI-4050 and Ryplazim(TM) (plasminogen) data on lung fibrosis at the 2019 ATS Conference
May 08, 2019
Prometic reports its 2019 first quarter financial results
Mar 26, 2019
Prometic to Report its Fourth Quarter and 2018 Year-End Financial Results and Hold Conference Call / Webcast
Feb 25, 2019
Prometic secures additional USD $10 million (CAD $13.2 million) tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities
Feb 14, 2019
Prometic retains investment bank for strategic transactions
Dec 05, 2018
Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome
Nov 28, 2018
Prometic Provides Corporate Update
Nov 14, 2018
Prometic Reports Third Quarter 2018 Financial Results and Highlights
Nov 14, 2018
Prometic Closes its Extension of Debt Maturities to 2024
Nov 12, 2018
Prometic to Report its Third Quarter 2018 Financial Results and Hold Conference Call / Webcast
Oct 29, 2018
Prometic Announces Extension of Debt Maturities to 2024
Oct 25, 2018
Prometic announces second annual Plasminogen Deficiency Awareness Week
Oct 16, 2018
Prometic announces positive feedback from FDA Type-C meeting on Ryplazim(TM) (plasminogen) BLA
Sep 05, 2018
Prometic to host Key Opinion Leader meeting on PBI-4050, a novel treatment for Alström Syndrome and promising therapeutic for non alcoholic steatohepatitis (NASH)
Aug 14, 2018
Prometic Reports Second Quarter 2018 Financial Results and Highlights
Aug 10, 2018
Prometic announces the publication of PBI-4050's antifibrotic activity in liver diseases in Journal of Pharmacology and Experimental Therapeutics